American Journal on Addictions

Papers
(The TQCC of American Journal on Addictions is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
2023 Reviewer List (n = 223)56
CME Posters (n = 64)28
The 24‐year course of substance use disorders in patients with borderline personality disorder and personality‐disordered comparison subjects24
Symposium II24
Proceedings of the 35th Annual Meeting & Scientific Symposium24
Call for Special Issue Papers 202520
Symposium I19
Paper sessions19
2025 Call for Symposium Abstracts19
Self assessment ad (002)17
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment17
Drug overdose and suicidal intentionality among young adults in methadone treatment17
Issue Information ‐ ToC16
Call for special issue 202214
2022: The Year in Review12
Call for special issue 202212
Call for Review Papers 202312
Issue Information12
Call for review papers 202310
Issue Information10
Call for review papers 20239
2022 Self‐Assessment examination9
Stand against stigma9
Stimulants PIP Ad9
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients9
AAAP on‐demand educational activities8
Issue Information8
Issue Information ‐ Editorial Board8
Call for review papers 20238
Issue Information8
Issue Information ‐ ToC7
7
Medication Management for Stimulant Use Disorder Webinar6
Is your AAAP Membership expiring this month?6
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem6
Addiction Psychiatry Advanced Psychotherapy Curriculum6
Is your AAAP membership expiring soon?6
Call for Special Issue 20246
Addiction Psychiatry Advanced Psychotherapy Curriculum6
6
Issue Information6
AAAP Annual Meeting Save the Date6
5
Become a AAAP Member5
AAAP 36th Annual Meeting & Scientific Symposium Save the Date5
AJA Stand Against Stigma5
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit5
Issue Information ‐ Editorial Board5
Stand against stigma5
Motivational Interviewing PIP5
Call for review papers 20235
Concurrent Paper Sessions5
Cannabis Use PIP Ad5
AAAP's Annual Meeting and Scientific Symposium5
Issue Information ‐ ToC5
Call for special issue 20235
5
Gender differences in circumstances associated with cannabis use5
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths4
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States4
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐194
AAAP 36th Annual Meeting & Scientific Symposium Save the Date4
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important4
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States4
AAAP Stimulant Use Disorder PIP4
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey4
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine4
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs4
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic4
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats3
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?3
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression3
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study3
2024 Annual Meeting Posters3
Risk factors for poor progression of addictive internet use across different COVID‐19 periods in China3
Interactive effects of ARRB2 and CHRNA5 genetic polymorphisms on cognitive function in Chinese male methamphetamine use disorder patients3
Do veterans with risky substance use (RSU) use distinct pain treatment modalities?3
Trends in cocaine use among United States females of reproductive age, 2005–20193
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada3
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt3
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic3
Daily cannabis use may cause cannabis‐induced hyperalgesia3
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial3
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US3
Predictors of abstinence maintenance after cocaine inpatient detoxification: A prospective study3
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts3
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–20213
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances3
AATT AAP on‐demand2
Become a member of AAAP!2
Mini‐Symposia II2
Save the Date AM 20242
Issue Information2
Clinical correlates of drug‐related dreams in opioid use disorder2
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report2
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey2
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States2
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes2
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health2
AAAP_Call for Special Issue Papers‐20242
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program2
Issue Information2
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20192
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort2
Symposium I2
Call for Review Papers 20242
Issue Information ‐ Editorial Board2
AAAP PIPS 20232
Call for review papers 20221
AAAP Membership Benefits1
Film & Media Workshop1
Nicotine Inhalation and Suicide: Clinical Correlates and Behavioral Mechanisms1
AAAP Annual meeting ad1
Is your AAAP Membership expiring this month?1
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study1
Call for special issue 20231
Call for review papers 20221
AAAP 31st Annual Meeting 2020 ‐ Meeting Recap1
Issue Information1
Posters1
CSAM‐SMCA 2022 Scientific conference and annual meeting1
Issue Information1
Binge drinking and sexual risk behavior among US sexual and gender minority college students1
Case Conference1
Alcohol and cannabis dual use among Black adults: Associations with alcohol use, use‐related problems, and race‐based discrimination1
Opioid Response Network1
Issue Information ‐ Editorial Board1
AAAP Membership1
AM Registration Flyer1
Issue Information1
Issue Information ‐ Editorial Board1
Issue Information1
AAAP's Self‐Assessment Examination 20201
2021 Annual Meeting Poster1
Psychotherapy webinar series AJA Ad1
Call for Special Issue 20211
Addiction Psychiatry Advanced Psychotherapy Curriculum1
Symposium III1
Conference Schedule1
2024 Annual Meeting Posters1
AAAP's Self‐Assessment Examination 20201
Stimulants Performance in Practice1
AATT AAP on‐demand1
ORN Advancing racial equity1
AATT & AAP1
Advanced Addiction Psychopharmacology1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use1
AAAP Membership benefits1
0.15544605255127